Tango Therapeutics (TNGX.US) Stock Community - Hot Topic Discussions

Event Tracking

Nov18

B. Riley Securities Maintains Buy Rating on Tango Therapeutics

14:17

Nov4

Tango Therapeutics released FY2025 9 Months Earnings on November 4 Pre-Market EST, with actual revenue of USD 62.38 M and EPS of USD -0.6435

14:30

Tango Therapeutics released FY2025 Q3 earnings on November 4 Pre-Market EST, actual revenue USD 53.81 M (forecast USD 41.24 M), actual EPS USD 0.13 (forecast USD -0.0137)

14:30

Tango Therapeutics Q3 EPS beats expectations

14:27

Tango Therapeutics Reports Q3 Net Income and Secures $225 Million Financing

14:07

Oct28

Tango Therapeutics to Release FY2025 Q3 Earnings on November 4, Pre-Market EST; Forecast Revenue USD 41.24 M, EPS USD -0.0137

00:06

Schedules & Filings

Schedules

Filings

Nov4

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 53.81 M, Net Income 15.88 M, EPS 0.13

Aug5

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.181 M, Net Income -38.85 M, EPS -0.3514

May12

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 5.392 M, Net Income -39.88 M, EPS -0.3615

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change